{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-24-000056","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2024-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.380047+00:00","generated_at":"2026-05-31T05:51:07.306962+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Bio-Rad amends bylaws to update stockholder meeting procedures and proxy rules","bullets":["Board amended Bylaws effective Sept 6, 2024, adding electronic stockholder meeting participation and universal proxy rule compliance.","Eliminated requirement to make stockholder list available at meetings.","Clarified CEO role as separate from President; required proxy solicitors to use non-white proxy card color.","Updated procedures for director nominations and other business proposals, including Rule 14a-19 universal proxy rules.","Made other administrative, clarifying, and conforming changes."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-24-000056","json":"https://secwatch.observer/filing/0000012208-24-000056.json","markdown":"https://secwatch.observer/filing/0000012208-24-000056.md","text":"https://secwatch.observer/filing/0000012208-24-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220824000056/0000012208-24-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220824000056/bio-20240906.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:51:07.306962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}